Back

The tolerability of Dapagliflozin in patients with heart failure with reduced ejection fraction when commenced in the acute inpatient setting

23 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 8 Pharmacotherapy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Harriet Young

Chelsea and Westminster Hospital NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

36 More presentations in this session

Presentation thumbnail
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure
Doctor M. Vaduganathan (Boston, US)
Abstract Slides
Presentation thumbnail
Guidelines-directed medical treatments in obese vs. non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry
Doctor C. Cappelletto (Trieste, IT)
Abstract Slides
Presentation thumbnail
Hyponatremia in stable patients with advanced heart failure: is the worse prognosis driven by altered hemodynamics?
Miss K. Rask (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Impact of trends in body mass index on outcomes in patients receiving HeartMate 3
Doctor A. daSilva-deAbreu (Rochester, US)
Abstract Slides
Presentation thumbnail
Cardiac magnetic resonance in etiological diagnosis and outcome of heart failure
Doctor J. Vieira (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 8

The Event

Event poster

Heart Failure 2022

23 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources